logo


FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Expires:February 28, 2011
Estimated average burden
hours per response0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
KANIA EDWIN M JR

(Last)(First)(Middle)
C/O EXACT SCIENCES CORPORATION, 100 CAMPUS DRIVE

(Street)
MARLBOROUGHMA07152

(City)(State)(Zip)
2. Issuer Name and Ticker or Trading Symbol
EXACT SCIENCES CORP [EXAS]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/20/2009
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock (1) 07/20/2009 A  5,339 A$ 0 172,503 D  
Common Stock         1,202,787 I See Footnote (2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. These shares of restricted stock were issued under the Company's 2000 Stock Option and Incentive Plan and vest 100% on the one-year anniversary of the date of grant in accordance with the Company's non-employee director compensation policy.
2. Consists of 726,999 shares beneficially owned by OneLiberty Fund III, L.P., of which OneLiberty Partners III, L.P. is the general partner. Also includes 465,096 shares beneficially owned by OneLiberty Fund IV, L.P., of which OneLiberty Partners IV, L.L.C. is the general partner, and 10,692 shares beneficially owned by OneLiberty Advisors Fund IV, L.P., of which OneLiberty Parters IV, L.L.C. is the general partner. Mr. Kania is a general partner of OneLiberty Partners III, L.P. and OneLiberty Partners IV, L.L.C. Mr. Kania may be deemed to share voting and investment power with respect to such shares and disclaims any beneficial ownership of such shares except to the extent of his pecuniary interest therein.
June Fontana, Power of Attorney07/21/2009
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

POWER OF ATTORNEY

The undersigned hereby constitutes and appoints each of 
Maneesh Arora, Mark Busch, June Fontana and Kyle Stacey, 
signing singly, as the undersigned?s true and lawful attorney-
in-fact to:

(1)execute for and on behalf of the undersigned, in 
the undersigned?s capacity as an officer and/or director of 
EXACT Sciences Corporation (the ?Company?), Forms 3, 4 and 5 
in accordance with Section 16(a) of the Securities Exchange 
Act of 1934 and the rules thereunder (the ?Exchange Act?), as 
well as the Form ID to obtain and/or renew EDGAR codes for use 
in connection with the filing of Forms 3, 4 and 5 and any 
other related documentation;

(2)do and perform any and all acts for and on behalf 
of the undersigned which may be necessary or desirable to 
complete and execute any such Forms 3, 4 or 5, Form ID or 
other related documentation, complete and execute any 
amendment or amendments thereto, and timely file such forms or 
documentation with the United States Securities and Exchange 
Commission and any stock exchange or similar authority;

(3)take any other action of any type whatsoever in 
connection with the foregoing which, in the opinion of such 
attorney-in-fact, may be of benefit to, in the best interest 
of, or legally required by, the undersigned, it being 
understood that the documents executed by such attorney-in-
fact on behalf of the undersigned pursuant to this Power of 
Attorney shall be in such form and shall contain such terms 
and conditions as such attorney-in-fact may approve in such 
attorney-in-fact?s discretion; and 

(4)in connection with the preparation and filing of 
Forms 3, 4 and 5, seek or obtain, as the undersigned?s 
attorney-in-fact and on the undersigned?s behalf, information 
regarding transactions in the Company?s securities from any 
third party, including brokers, employee benefit plan 
administrators and trustees, and the undersigned hereby 
authorizes any such person to release any such information to 
such attorney-in-fact and approves and ratifies any such 
release of information. 

The undersigned hereby grants to each such attorney-in-
fact full power and authority to do and perform any and every 
act and thing whatsoever requisite, necessary, or proper to be 
done in connection with the exercise of any of the rights and 
powers herein granted, as fully to all intents and purposes as 
the undersigned might or could do if personally present, with 
full power of substitution or revocation, herby ratifying and 
confirming all that such attorney-in-fact, or such attorney-
in-fact?s substitute or substitutes, shall lawfully do or 
cause to be done by virtue of this Power of Attorney and the 
rights and powers herein granted.  The undersigned 
acknowledges that the foregoing attorneys-in-fact, in serving 
in such capacity at the request of the undersigned, are not 
assuming, nor is the Company assuming, any of the 
undersigned?s responsibilities to comply with Section 16 of 
the Exchange Act.

This Power of Attorney shall remain in full force and 
effect until the undersigned is no longer required to file 
Forms 3, 4, and 5 with respect to the undersigned?s holdings 
of and transactions in securities issued by the Company, 
unless earlier revoked by the undersigned in a signed writing 
delivered to the foregoing attorneys-in-fact.  

This Power of Attorney does not relieve the undersigned 
from responsibility for compliance with the undersigned?s 
obligations under the Exchange Act, including, without 
limitation, the reporting requirements under Section 16 of the 
Exchange Act.  Additionally, although pursuant to this Power 
of Attorney the Company will use commercially reasonable
best efforts to timely and accurately file Section 16 reports 
on behalf of the undersigned, the Company does not represent 
or warrant that it will be able to in all cases timely and 
accurately file Section 16 reports on behalf of the 
undersigned due to various factors, including, but not limited 
to, the shorter deadlines mandated by the Sarbanes-Oxley Act 
of 2002, possible time zone differences between the Company 
and the undersigned and the Company?s need to rely on other 
parties for information, including the undersigned and brokers 
of the undersigned.

IN WITNESS WHEREOF, the undersigned has caused this 
Power of Attorney to be executed as of this 17th day of July, 
2009.



/s/ Edwin Kania, Jr.
Edwin M. Kania, Jr.




Add to Delicious   Add to DeliciousDigg It  Digg It
Send Email Send by Email Send Email Post Comment

 
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia